Serum IgG3 levels in people with CIS correlated with proportions of circulating plasmablasts (CD19+CD20−CD38hiCD27hiIgD−CD24−), cells which are increased in the CSF of people with MS (25). Here, IGHG3 is linked to myeloid sarcoma.